NONCLASSICAL PLATINUM ANTITUMOR AGENTS - PERSPECTIVES FOR DESIGN AND DEVELOPMENT OF NEW DRUGS COMPLEMENTARY TO CISPLATIN

被引：115

作者：

FARRELL, N ^{[1
]}

机构：

[1] UNIV VERMONT,VERMONT CANC CTR,BURLINGTON,VT 05405

来源：

CANCER INVESTIGATION | 1993年 / 11卷 / 05期

关键词：

D O I：

10.3109/07357909309011676

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：578 / 589

页数：12

共 74 条

[1]

ADOMAT H, 1991, Anti-Cancer Drug Design, V6, P233

[2]

ANDREWS PA, 1990, CANCER CELL-MON REV, V2, P35

[3] PT-195 NMR KINETIC AND MECHANISTIC STUDIES OF CIS-DIAMMINEDICHLOROPLATINUM AND TRANS-DIAMMINEDICHLOROPLATINUM(II) BINDING TO DNA [J].

BANCROFT, DP ;

LEPRE, CA ;

LIPPARD, SJ .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1990, 112 (19) :6860-6871

[4] DNA UNWINDING PRODUCED BY SITE-SPECIFIC INTRASTRAND CROSS-LINKS OF THE ANTITUMOR DRUG CIS-DIAMMINEDICHLOROPLATINUM(II) [J].

BELLON, SF ;

COLEMAN, JH ;

LIPPARD, SJ .

BIOCHEMISTRY, 1991, 30 (32) :8026-8035

[5] REACTION OF CIS-[PTCL2(NH3)2] AND TRANS-[PTCL2(NH3)2] WITH REDUCED GLUTATHIONE STUDIED BY H-1-[H-1], C-13[H-1], PT-195[H-1] AND N-15-[H-1] DEPT NMR [J].

BERNERSPRICE, SJ ;

KUCHEL, PW .

JOURNAL OF INORGANIC BIOCHEMISTRY, 1990, 38 (04) :305-326

[6] THE DINUCLEAR COMPLEX [(TRANS-PTCL(NH3)2)2(MU-H2N(CH2)6NH2)]CL2 FORMS A UNIQUE MACROCHELATE INTRASTRAND CROSS-LINK WITH D(GPG) [J].

BLOEMINK, MJ ;

REEDIJK, J ;

FARRELL, N ;

QU, Y ;

STETSENKO, AI .

JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1992, (14) :1002-1003

[7]

BODENNER DL, 1986, CANCER RES, V46, P2745

[8]

Boyd M.K., 1989, CANCER PRINCIPLES PR, V3, P1

[9] SPECTRUM OF CISPLATIN-INDUCED MUTATIONS IN ESCHERICHIA-COLI [J].

BURNOUF, D ;

DAUNE, M ;

FUCHS, RPP .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (11) :3758-3762

[10]

CANETTA R, 1990, CANCER CHEMOTHERAPY, V5, P318

← 1 2 3 4 5 6 7 8 →